While the headline numbers don't inspire much confidence, Moderna is a stock that deserves a closer look. The company still ...

Rae Hartley Beck first started writing about personal finance in 2011 with a regular column in her college newspaper as a staff writer. Since then she has become a leader in the Financial ...

“You, Me & Her,” an R-rated indie romantic comedy, will be the first film to use the new Attend direct distribution platform recently launched by The Fithian Group. The film, a Two Hands ...

Moderna (NASDAQ: MRNA) was one of the hottest companies of early pandemic times, delivering a coronavirus vaccine to market in record time and quickly generating blockbuster revenue from it.

Moderna’s mRNA-1403 is a messenger RNA-based trivalent vaccine candidate designed to protect against multiple norovirus genotypes. Moderna provided an update on the status of its trial ...

Shares of Moderna Inc. fell sharply on Monday after the biotech firm projected a steep decline in 2025 revenues, falling below Wall Street expectations. The company, known for its COVID-19 vaccine ...

That’s why the volume and sound levels are very low while you are watching a movie or video on Your PC. Luckily, with a third-party volume booster, you can drastically increase the volume levels of ...

Therefore, our research team has developed a portable cardiopulmonary function measurement device named “Booster,” which utilizes sequential respiration method and incorporates multiple sensors to ...

People age 12 and older may be eligible for a COVID-19 booster depending on which vaccine ... and matching their boosters at the moment. Moderna submitted data to the Food and Drug Administration ...

Moderna's partnership with Merck in personalized ... the development of their 10 most promising product candidates with near-term commercial potential. Beyond the oncology product candidates ...